• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在纤维化背景下阐明气体介质的分子途径和治疗干预措施。

Elucidating the Molecular Pathways and Therapeutic Interventions of Gaseous Mediators in the Context of Fibrosis.

作者信息

Li Aohan, Wu Siyuan, Li Qian, Wang Qianqian, Chen Yingqing

机构信息

Chronic Disease Research Center, Medical College, Dalian University, Dalian 116622, China.

Engineering Technology Research Center for The Utilization of Functional Components of Organic Natural Products, Dalian University, Dalian 116622, China.

出版信息

Antioxidants (Basel). 2024 Apr 25;13(5):515. doi: 10.3390/antiox13050515.

DOI:10.3390/antiox13050515
PMID:38790620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11117599/
Abstract

Fibrosis, a pathological alteration of the repair response, involves continuous organ damage, scar formation, and eventual functional failure in various chronic inflammatory disorders. Unfortunately, clinical practice offers limited treatment strategies, leading to high mortality rates in chronic diseases. As part of investigations into gaseous mediators, or gasotransmitters, including nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (HS), numerous studies have confirmed their beneficial roles in attenuating fibrosis. Their therapeutic mechanisms, which involve inhibiting oxidative stress, inflammation, apoptosis, and proliferation, have been increasingly elucidated. Additionally, novel gasotransmitters like hydrogen (H) and sulfur dioxide (SO) have emerged as promising options for fibrosis treatment. In this review, we primarily demonstrate and summarize the protective and therapeutic effects of gaseous mediators in the process of fibrosis, with a focus on elucidating the underlying molecular mechanisms involved in combating fibrosis.

摘要

纤维化是修复反应的一种病理改变,涉及多种慢性炎症性疾病中的持续性器官损伤、瘢痕形成以及最终的功能衰竭。不幸的是,临床实践中的治疗策略有限,导致慢性病死亡率很高。作为对包括一氧化氮(NO)、一氧化碳(CO)和硫化氢(HS)等气态介质或气体信号分子研究的一部分,大量研究证实了它们在减轻纤维化方面的有益作用。它们的治疗机制,包括抑制氧化应激、炎症、细胞凋亡和增殖,已得到越来越多的阐明。此外,像氢气(H)和二氧化硫(SO)等新型气体信号分子已成为纤维化治疗的有前景的选择。在这篇综述中,我们主要展示并总结气态介质在纤维化过程中的保护和治疗作用,重点是阐明对抗纤维化所涉及的潜在分子机制。

相似文献

1
Elucidating the Molecular Pathways and Therapeutic Interventions of Gaseous Mediators in the Context of Fibrosis.在纤维化背景下阐明气体介质的分子途径和治疗干预措施。
Antioxidants (Basel). 2024 Apr 25;13(5):515. doi: 10.3390/antiox13050515.
2
Gasotransmitters: Potential Therapeutic Molecules of Fibrotic Diseases.气体信号分子:纤维化疾病的潜在治疗分子。
Oxid Med Cell Longev. 2021 Sep 20;2021:3206982. doi: 10.1155/2021/3206982. eCollection 2021.
3
Recent advances on endogenous gasotransmitters in inflammatory dermatological disorders.炎症性皮肤疾病中内源性气体信号分子的最新进展。
J Adv Res. 2021 Sep 1;38:261-274. doi: 10.1016/j.jare.2021.08.012. eCollection 2022 May.
4
Gaseous mediators in resolution of inflammation.炎症消退过程中的气态介质。
Semin Immunol. 2015 May;27(3):227-33. doi: 10.1016/j.smim.2015.05.004. Epub 2015 Jun 18.
5
Gases in Sepsis: Novel Mediators and Therapeutic Targets.脓毒症中的气体:新型介质和治疗靶点。
Int J Mol Sci. 2022 Mar 27;23(7):3669. doi: 10.3390/ijms23073669.
6
Role of Gasotransmitters in Inflammatory Edema.气体递质在炎性水肿中的作用。
Antioxid Redox Signal. 2024 Feb;40(4-6):272-291. doi: 10.1089/ars.2022.0089. Epub 2023 May 23.
7
The Role of Gasotransmitter-Dependent Signaling Mechanisms in Apoptotic Cell Death in Cardiovascular, Rheumatic, Kidney, and Neurodegenerative Diseases and Mental Disorders.气体信号分子依赖的信号机制在心血管疾病、风湿性疾病、肾脏疾病、神经退行性疾病和精神障碍中的细胞凋亡中的作用。
Int J Mol Sci. 2023 Mar 23;24(7):6014. doi: 10.3390/ijms24076014.
8
Interaction among Hydrogen Sulfide and Other Gasotransmitters in Mammalian Physiology and Pathophysiology.硫化氢与其他气体递质在哺乳动物生理学和病理生理学中的相互作用。
Adv Exp Med Biol. 2021;1315:205-236. doi: 10.1007/978-981-16-0991-6_9.
9
Emergence of hydrogen sulfide as an endogenous gaseous signaling molecule in cardiovascular disease.内源性气体信号分子硫化氢在心血管疾病中的作用。
Circ Res. 2014 Feb 14;114(4):730-7. doi: 10.1161/CIRCRESAHA.114.300505.
10
Garlic and Gaseous Mediators.大蒜与气态介质。
Trends Pharmacol Sci. 2018 Jul;39(7):624-634. doi: 10.1016/j.tips.2018.03.009. Epub 2018 Apr 26.

引用本文的文献

1
Molecular hydrogen and kidney diseases: a scoping review based on scientometry and data analytics.分子氢与肾脏疾病:基于科学计量学和数据分析的综述
Med Gas Res. 2026 Jun 1;16(2):161-168. doi: 10.4103/mgr.MEDGASRES-D-25-00047. Epub 2025 Aug 18.
2
The role of macrophages in hypertrophic scarring: molecular to therapeutic insights.巨噬细胞在增生性瘢痕形成中的作用:从分子机制到治疗见解
Front Immunol. 2025 Mar 28;16:1503985. doi: 10.3389/fimmu.2025.1503985. eCollection 2025.

本文引用的文献

1
Endogenous sulfur dioxide deficiency as a driver of cardiomyocyte senescence through abolishing sulphenylation of STAT3 at cysteine 259.内源性二氧化硫缺乏通过消除 STAT3 半胱氨酸 259 的磺基化来驱动心肌细胞衰老。
Redox Biol. 2024 May;71:103124. doi: 10.1016/j.redox.2024.103124. Epub 2024 Mar 13.
2
Exploring the therapeutic potential of a nano micelle containing a carbon monoxide-releasing molecule for metabolic-associated fatty liver disease by modulating hypoxia-inducible factor-1α.探讨通过调节缺氧诱导因子-1α,一种含有一氧化碳释放分子的纳米胶束在代谢相关脂肪性肝病治疗中的应用潜力。
Acta Biomater. 2023 Oct 1;169:500-516. doi: 10.1016/j.actbio.2023.08.009. Epub 2023 Aug 12.
3
Gasotransmitters in non-alcoholic fatty liver disease: just the tip of the iceberg.
非酒精性脂肪性肝病中的气体信号分子:冰山一角。
Eur J Pharmacol. 2023 Sep 5;954:175834. doi: 10.1016/j.ejphar.2023.175834. Epub 2023 Jun 16.
4
CO-Induced TTP Activation Alleviates Cellular Senescence and Age-Dependent Hepatic Steatosis Downregulation of .一氧化碳诱导的血栓性血小板减少性紫癜激活减轻细胞衰老和年龄依赖性肝脂肪变性下调。
Aging Dis. 2023 Apr 1;14(2):484-501. doi: 10.14336/AD.2023.0120.
5
[Sulfur dioxide in the caudal ventrolateral medulla reduces blood pressure and heart rate in rats via the glutamate receptor and NOS/cGMP signal pathways].[延髓尾端腹外侧部的二氧化硫通过谷氨酸受体及一氧化氮合酶/环磷酸鸟苷信号通路降低大鼠血压和心率]
Sheng Li Xue Bao. 2023 Feb 25;75(1):27-35.
6
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation.纤维化:类型、影响、标志物、疾病进展的机制及其与氧化应激、免疫和炎症的关系。
Int J Mol Sci. 2023 Feb 16;24(4):4004. doi: 10.3390/ijms24044004.
7
Delivery of nitric oxide with a pH-responsive nanocarrier for the treatment of renal fibrosis.pH 响应性纳米载体递送一氧化氮治疗肾纤维化。
J Control Release. 2023 Feb;354:417-428. doi: 10.1016/j.jconrel.2022.12.059. Epub 2023 Jan 18.
8
Elucidating the role of circNFIB in myocardial fibrosis alleviation by endogenous sulfur dioxide.阐明内源性二氧化硫通过 circNFIB 减轻心肌纤维化的作用。
BMC Cardiovasc Disord. 2022 Nov 20;22(1):492. doi: 10.1186/s12872-022-02909-x.
9
Macrophage autophagy in macrophage polarization, chronic inflammation and organ fibrosis.巨噬细胞自噬在巨噬细胞极化、慢性炎症和器官纤维化中的作用。
Front Immunol. 2022 Oct 6;13:946832. doi: 10.3389/fimmu.2022.946832. eCollection 2022.
10
Controlled therapeutic delivery of CO from carbon monoxide-releasing molecules (CORMs).一氧化碳释放分子(CORMs)控制治疗递送 CO。
J Control Release. 2022 Oct;350:652-667. doi: 10.1016/j.jconrel.2022.08.055. Epub 2022 Sep 7.